Profile
| Metric | Value |
|---|---|
| Full Name | BeiGene, Ltd. |
| Ticker | NASDAQ: BGNE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Cayman Islands |
| IPO | |
| Indexes | Not included |
| Website | beigene.com |
| Employees | 10,600 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| - | ||
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $2B | ||
| Revenue, 1Y Change | +73.65% | |
| -$8.45 | ||
| EPS, 1Y Change | +56.38% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$8.45 | ||
| EPS Estimate | N/A | -$4.90 |
| EPS Est. Change | N/A | +42.00% |
| $2.46B | ||
| Revenue Estimate | N/A | $3.71B |
| Revenue Est. Change | N/A | +50.73% |
| - | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$8.60 | -$8.45 | +1.74% | |
| -$4.90 | N/A | +42.00% | |
| -$0.56 | N/A | +93.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.45B | $2.46B | +0.18% | |
| $3.71B | N/A | +50.73% | |
| $4.67B | N/A | +89.98% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +73.65% | ||
| +696.05% | ||
| +56.38% | ||
| +56.67% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| - | ||
| N/A | - | |
| SMA 200 vs Price | N/A | - |
| N/A | - | |
| SMA 50 vs Price | N/A | - |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.46B | ||
| -$8.45 | ||
| $2.08B | ||
| 84.55% | ||
| -$1.21B | ||
| -49.12% | ||
| -$881.71M | ||
| -35.86% | ||
| -$1.12B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.25 | ||
| 2.32 | ||
| 2.09 | ||
| - | ||
| 3 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $3.54B | ||
| $3.17B | ||
| $5.81B | ||
| $4.20B | ||
| $2.27B | ||
| $1.81B | ||
| $930.19M | ||
| $710.32M | ||
| $315.11M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $3.67B | ||
| $3.29B | ||
| $379.92M | ||
| $1.50B | ||
| $87.68M | ||
| - | ||
| $55.87M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$1.16B | ||
| $60.00M | ||
| $416.48M | ||
| $596.26M | ||
| -$1.75B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| JP Morgan | → | |
| JMP Securities | ||
| JP Morgan | → | |
| Citigroup | → | |
| B of A Securities | → | |
| TD Cowen | → | |
| TD Cowen | → | |
| B of A Securities | → | |
| Bernstein | → |
Analyst sentiment
Institutional ownership
Screeners with BGNE
Data Sources & References
- BGNE Official Website www.beigene.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1651308/000165130824000014/0001651308-24-000014-index.htm
- BGNE Profile on Yahoo Finance finance.yahoo.com/quote/BGNE
- BGNE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bgne
FAQ
What is the ticker symbol for BeiGene, Ltd.?
The ticker symbol for BeiGene, Ltd. is NASDAQ:BGNE
Does BeiGene, Ltd. pay dividends?
No, BeiGene, Ltd. does not pay dividends
What sector is BeiGene, Ltd. in?
BeiGene, Ltd. is in the Healthcare sector
What industry is BeiGene, Ltd. in?
BeiGene, Ltd. is in the Biotechnology industry
What country is BeiGene, Ltd. based in?
BeiGene, Ltd. is headquartered in Cayman Islands
When did BeiGene, Ltd. go public?
BeiGene, Ltd. initial public offering (IPO) was on February 3, 2016
Is BeiGene, Ltd. in the S&P 500?
No, BeiGene, Ltd. is not included in the S&P 500 index
Is BeiGene, Ltd. in the NASDAQ 100?
No, BeiGene, Ltd. is not included in the NASDAQ 100 index
Is BeiGene, Ltd. in the Dow Jones?
No, BeiGene, Ltd. is not included in the Dow Jones index
When was BeiGene, Ltd. last earnings report?
BeiGene, Ltd.'s most recent earnings report was on February 26, 2025
When does BeiGene, Ltd. report earnings?
The date for BeiGene, Ltd.'s next earnings report has not been announced yet